MedTrace Logo

Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease

NCT06673134 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-04

No results posted yet for this study

Summary

To evaluate the clinical manifestations, treatment options, and improved clinical outcomeof children with Crohn's disease in real-world Settings: (1) analysis of clinical manifestations; (2) probability of using the same treatment options; (3) Clinical outcome;

Conditions

  • Crohn Disease

Interventions

DRUG

enteral nutrition

exclusive enteral nutrition therapy or Partial enteral nutrition

DRUG

Immunotherapy

Immunosuppressants therapy, Including thalidomide, azathioprine, methotrexate, etc

DRUG

biological agents

Inflixima , domestic infliximab (Taizhou Mabtech Pharmaceutical Co.,Ltd) and Adalimumab , etc

DRUG

Glucocorticoids

Glucocorticoids treatments are given

OTHER

fecal microbiota transplantation

Fecal bacteria transplantation treatment, transplantation routes include enema, TET route, capsule fecal bacteria route, etc

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Zhihua Huang Huang, Pro · Huazhong University of Science and Technology

Eligibility

Min Age
1 Month
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2026-07-24
Completion
2028-07-24

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06673134 on ClinicalTrials.gov